. . "Antineoplastic agents"@en . _:b7iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b7iddOtlocdOtgovauthoritiessubjectssh85005714 _:b8iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b7iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b8iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b8iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastic agents"@en . _:b11iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b11iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b11iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b11iddOtlocdOtgovauthoritiessubjectssh85005714 "Anticancer agents"@en . _:b11iddOtlocdOtgovauthoritiessubjectssh85005714 _:b16iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b16iddOtlocdOtgovauthoritiessubjectssh85005714 _:b17iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b16iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b17iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b17iddOtlocdOtgovauthoritiessubjectssh85005714 "Anticancer agents"@en . _:b20iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b20iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b20iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b20iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastic drugs"@en . _:b20iddOtlocdOtgovauthoritiessubjectssh85005714 _:b25iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b25iddOtlocdOtgovauthoritiessubjectssh85005714 _:b26iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b25iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b26iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b26iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastic drugs"@en . _:b29iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b29iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b29iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b29iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastics"@en . _:b29iddOtlocdOtgovauthoritiessubjectssh85005714 _:b34iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b34iddOtlocdOtgovauthoritiessubjectssh85005714 _:b35iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b34iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b35iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b35iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastics"@en . _:b38iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b38iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b38iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b38iddOtlocdOtgovauthoritiessubjectssh85005714 "Antitumor agents"@en . _:b38iddOtlocdOtgovauthoritiessubjectssh85005714 _:b43iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b43iddOtlocdOtgovauthoritiessubjectssh85005714 _:b44iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b43iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b44iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b44iddOtlocdOtgovauthoritiessubjectssh85005714 "Antitumor agents"@en . _:b47iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b47iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b47iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b47iddOtlocdOtgovauthoritiessubjectssh85005714 "Antitumor drugs"@en . _:b47iddOtlocdOtgovauthoritiessubjectssh85005714 _:b52iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b52iddOtlocdOtgovauthoritiessubjectssh85005714 _:b53iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b52iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b53iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b53iddOtlocdOtgovauthoritiessubjectssh85005714 "Antitumor drugs"@en . _:b56iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b56iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b56iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b56iddOtlocdOtgovauthoritiessubjectssh85005714 "Cytotoxic drugs"@en . _:b56iddOtlocdOtgovauthoritiessubjectssh85005714 _:b61iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b61iddOtlocdOtgovauthoritiessubjectssh85005714 _:b62iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b61iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b62iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b62iddOtlocdOtgovauthoritiessubjectssh85005714 "Cytotoxic drugs"@en . _:b65iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b65iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b65iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b65iddOtlocdOtgovauthoritiessubjectssh85005714 "Inhibitors, Neoplasm"@en . _:b65iddOtlocdOtgovauthoritiessubjectssh85005714 _:b70iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b70iddOtlocdOtgovauthoritiessubjectssh85005714 _:b71iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b70iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b71iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b71iddOtlocdOtgovauthoritiessubjectssh85005714 "Inhibitors, Neoplasm"@en . _:b74iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b74iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b74iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b74iddOtlocdOtgovauthoritiessubjectssh85005714 "Neoplasm inhibitors"@en . _:b74iddOtlocdOtgovauthoritiessubjectssh85005714 _:b79iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b79iddOtlocdOtgovauthoritiessubjectssh85005714 _:b80iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b79iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b80iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b80iddOtlocdOtgovauthoritiessubjectssh85005714 "Neoplasm inhibitors"@en . "150 0$aAntineoplastic agents" . _:b85iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b85iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b85iddOtlocdOtgovauthoritiessubjectssh85005714 "RC271.C5" . _:b85iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b90iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b90iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b90iddOtlocdOtgovauthoritiessubjectssh85005714 "RS431.A64" . _:b90iddOtlocdOtgovauthoritiessubjectssh85005714 . . . "Bromebric acid"@en . . . "Fareston"@en . . . "Docetaxel"@en . . . "Antineoplastic antibiotics"@en . . . "Oxaliplatin"@en . . . "Neovascularization inhibitors"@en . . . "Goserelin"@en . . . "Antineoplastic agents--Physiological effect" . . . "Vinblastine"@en . . . "Laetrile"@en . . . "Krebiozen"@en . . . "Arabinonucleosides"@en . . . "Antitumorali"@it . . . "Fluorouracil"@en . . . "Antineoplastic agents--Side effects" . . . "Interferon"@en . . . "Antineoplastic agents--Mechanism of action" . . . "Tamoxifen"@en . . . "antineoplastic agents"@en . . . "Curcumin"@en . . . "Puromycin"@en . . . "Phorboxazoles"@en . . . "Antineoplastic agents--Synthesis" . . . "Bisantrene hydrochloride"@en . . . "Quinacrine"@en . . . "Antineoplastic agents--Administration" . . . "Octreotide acetate"@en . . . "Vinorelbine"@en . . . . "Drugs"@en . _:b212iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b212iddOtlocdOtgovauthoritiessubjectssh85005714 _:b213iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b212iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b213iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b213iddOtlocdOtgovauthoritiessubjectssh85005714 "Drugs"@en . . . "Azacitidine"@en . . . "Cytostatikum" . . . "Anticancéreux"@fr . . . "Antineoplastic agents--Research" . . . "Lapatinib"@en . . . "Antineoplásicos"@es . . . "Paclitaxel"@en . . . "Methotrexate"@en . . . "Cetuximab"@en . . . "Antineoplastic agents--Metabolism" . . . . "Cancer--Chemotherapy"@en . _:b261iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b261iddOtlocdOtgovauthoritiessubjectssh85005714 _:b262iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b261iddOtlocdOtgovauthoritiessubjectssh85005714 _:b0269 . _:b262iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b262iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b262iddOtlocdOtgovauthoritiessubjectssh85005714 "Cancer"@en . _:b262iddOtlocdOtgovauthoritiessubjectssh85005714 _:b266iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b266iddOtlocdOtgovauthoritiessubjectssh85005714 _:b267iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b266iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b267iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b267iddOtlocdOtgovauthoritiessubjectssh85005714 "Cancer"@en . _:b0269 _:b270iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b0269 . _:b270iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b270iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b270iddOtlocdOtgovauthoritiessubjectssh85005714 "Chemotherapy"@en . _:b270iddOtlocdOtgovauthoritiessubjectssh85005714 _:b274iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b274iddOtlocdOtgovauthoritiessubjectssh85005714 _:b275iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b274iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b275iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b275iddOtlocdOtgovauthoritiessubjectssh85005714 "Chemotherapy"@en . . . "Antineoplastic agents--Analysis" . . . "Antineoplastic agents--Safety measures" . . . "Vindesine"@en . . . "Mitoxantrone hydrochloride"@en . . . "Antineoplastic agents--Toxicology" . . . "Vincristine"@en . . . "Bestatin"@en . . . "Methisazone"@en . . . "Camptothecin"@en . . . "Etoposide"@en . . . "Imatinib"@en . . . "antineoplastic agents"@en . . . "Antimetabolites"@en . . . "Lonidamine"@en . . . "Trastuzumab"@en . . . "Rituximab"@en . . . "Folinic acid"@en . . . "Antineoplastic agents--Structure-activity relationships" . . . "Fludarabine"@en . . . "Antineoplastic agents" . . . "Antineoplastic agents--Therapeutic use" . . . "Bevacizumab"@en . . . "制癌剤" . . . "Antineoplastic agents--Design" . . . "Cisplatin"@en . . . . . . "A clinician's guide to chemotherapy pharmacokinetics and pharmacodynamics" . . . "Advances in studies on enzyme inhibitors as drugs" . . . "Anticancer agents from natural products" . . . "Anticancer agents from natural products" . . . "Anticancer drug development" . . . "Anticancer drugs" . . . "Anticancer therapeutics" . . . "Antitumor potential and other emerging medicinal properties of natural compounds" . . . "Bloom, Roger Cancer medicine from nature" . . . "Bortezomib in the treatment of multiple myeloma" . . . "Bucay, José Waizel Cultivo, aislamiento y variación de principios activos de tres especies de plantas, con propiedades anticancerígenas" . . . "Cancer" . . . "Cancer chemotherapy" . . . "Cancer chemotherapy 1" . . . "Cancer chemotherapy and biotherapy" . . . "Cancer chemotherapy and biotherapy" . . . "Cancer chemotherapy and biotherapy" . . . "Cancer targeted drug delivery" . . . "Cardiotoxicity of chemotherapeutic agents" . . . "Carter, Stephen K., 1937- Chemotherapy of cancer" . . . "Cell apoptosis research trends" . . . "Cell cycle effects of drugs" . . . "Checkpoint Responses in Cancer Therapy" . . . "Chemotherapy of gynecologic cancer" . . . "Chen, Qingqi, 1963- Kang ai xin yao yan jiu zhi nan" . . . "Clarysse, A., 1936- Cancer chemotherapy" . . . "Colvin, Michael Engineering cancer drugs" . . . "Concepts in oncology therapeutics" . . . "Concepts, clinical developments, and therapeutic advances in cancer chemotherapy" . . . "Delivery of protein and peptide drugs in cancer" . . . "Deoxynucleoside analogs in cancer therapy" . . . "Developments in cancer chemotherapy" . . . "Dose intensity" . . . "Doxorubicin" . . . "Drugs affecting growth of tumours" . . . "Evidence-based anticancer materia medica" . . . "Fundamentals of cancer chemotherapy" . . . "Getoff, Nikola, 1922- Free radicals effect on cytostatica, vitamins, hormones and phytocompounds with respect to cancer" . . . "Harrison's manual of oncology" . . . "Heterocyclic antitumor antibiotics" . . . "Hoffman, Edward J. Cancer and the search for selective biochemical inhibitors" . . . "Immunomodulatory and cytotoxic agents in dermatology" . . . "Jin, Tao Wei sheng wu fa jiao sheng chan zi shan chun yan jiu" . . . "Kinase inhibitor drugs" . . . "Knock, Frances E. Anticancer agents" . . . "Kupchan, S. Morris Plants against cancer" . . . "Lacroix, Marc, 1963- Molecular therapy of breast cancer" . . . "LaValle, James B. The Cox-2 connection" . . . "Lednicer, Daniel, 1929- Antineoplastic drugs" . . . "Lednicer, Daniel, 1929- Antineoplastic drugs" . . . "Macromolecular anticancer therapeutics" . . . "Matthews, David J. (David John), 1965- Targeting protein kinases for cancer therapy" . . . "Metal compounds in cancer chemotherapy 2005" . . . "Metal-based anticancer agents" . . . "Metallo-drugs" . . . "Molecular orbital calculations for biological systems" . . . "Multimodal concepts for integration of cytotoxic drugs" . . . "Nanotechnology for cancer therapy" . . . "New drugs, concepts, and results in cancer chemotherapy" . . . "New skin toxicities for new anticancer therapies" . . . "New skin toxicities for new anticancer therapies" . . . "Nitric oxide (NO) and cancer" . . . "Novel apoptotic drugs in targeting tumor cells" . . . "O Ipê roxo (pau d'arco)" . . . "Outline of oncology therapeutics" . . . "Parfenov, E. A. Biometals and ligands for anticancer drug design" . . . "Pentacyclic triterpenes as promising agents in cancer" . . . "Pentacyclic triterpenes as promising agents in cancer" . . . "Pharmaceutical formulation and medicinal chemistry" . . . "Pharmaceutical formulation and medicinal chemistry" . . . "Pharmaceutical perspectives of cancer therapeutics" . . . "Pharmacokinetics and cancer chemotherapy" . . . "Phytochemicals as bioactive agents" . . . "Preston, Fredrica A. Memory bank for chemotherapy" . . . "Principles of anticancer drug development" . . . "Protivoopukholevye soedinenii︠a︡ pi︠a︡ti-nitrofuranovogo ri︠a︡da" . . . "Resistance to antineoplastic drugs" . . . "Rituximab" . . . "Rituximab" . . . "Rituximab-mediated molecular signaling and interactions with chemotherapeutic drugs" . . . "Rizzini, Jorge A verdade sôbre o ipê-roxo" . . . "Shein, P Cancer and a new drug" . . . "Silver, Richard T., 1929- A synopsis of cancer chemotherapy" . . . "Small molecules in oncology" . . . "Sŭmatʻŭ nano ipcha rŭl iyonghan chʻŏnyŏnmul yurae yangni hwalsŏng mulchil (hangamje, myŏnyŏk hwalsŏngje) ŭi yangmul chŏndal yudo misairhwa e kwanhan yŏnʼgu" . . . "Targeted therapies for solid tumors" . . . "The anticancer drugs" . . . "The chemotherapy source book" . . . "The chemotherapy source book" . . . "The chemotherapy source book" . . . "The Chemotherapy source book" . . . "The market for cancer therapeutics and diagnostics" . . . "The Search for new anticancer drugs" . . . "Therapeutic kinase inhibitors" . . . "Thurston, David E. Chemistry and pharmacology of anticancer drugs" . . . "Treatment of acute leukemias" . . . "Voprosy radiobiologii i biologicheskogo deĭstvii︠a︡ t︠s︡itostaticheskikh preparatov" . . . "Wilkes, Gail M. 1997-1998 oncology nursing drug handbook" . . . "Wilkes, Gail M. Patient education guide to oncology drugs" . . . "Zhou, J. (Jiaju) Zhong yao kang ai huo xing cheng fen" . . "sh 85005714" . . . _:b786iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b786iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b786iddOtlocdOtgovauthoritiessubjectssh85005714 "Common usage in oncology." . _:b786iddOtlocdOtgovauthoritiessubjectssh85005714 "found" . _:b792iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b792iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b792iddOtlocdOtgovauthoritiessubjectssh85005714 "1986-02-11T00:00:00"^^ . _:b792iddOtlocdOtgovauthoritiessubjectssh85005714 "new"^^ . _:b792iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b799iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b799iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b799iddOtlocdOtgovauthoritiessubjectssh85005714 "1993-05-03T10:53:17"^^ . _:b799iddOtlocdOtgovauthoritiessubjectssh85005714 "revised"^^ . _:b799iddOtlocdOtgovauthoritiessubjectssh85005714 . . "Antineoplastic agents"@en . _:b809iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b809iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b809iddOtlocdOtgovauthoritiessubjectssh85005714 "Anticancer agents"@en . _:b814iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b814iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b814iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastic drugs"@en . _:b819iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b819iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b819iddOtlocdOtgovauthoritiessubjectssh85005714 "Antineoplastics"@en . _:b824iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b824iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b824iddOtlocdOtgovauthoritiessubjectssh85005714 "Antitumor agents"@en . _:b829iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b829iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b829iddOtlocdOtgovauthoritiessubjectssh85005714 "Antitumor drugs"@en . _:b834iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b834iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b834iddOtlocdOtgovauthoritiessubjectssh85005714 "Cytotoxic drugs"@en . _:b839iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b839iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b839iddOtlocdOtgovauthoritiessubjectssh85005714 "Inhibitors, Neoplasm"@en . _:b844iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b844iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b844iddOtlocdOtgovauthoritiessubjectssh85005714 "Neoplasm inhibitors"@en . . . "Drugs"@en . . . "Bromebric acid"@en . . . "Fareston"@en . . . "Docetaxel"@en . . . "Antineoplastic antibiotics"@en . . . "Oxaliplatin"@en . . . "Neovascularization inhibitors"@en . . . "Goserelin"@en . . . "Vinblastine"@en . . . "Laetrile"@en . . . "Krebiozen"@en . . . "Arabinonucleosides"@en . . . "Fluorouracil"@en . . . "Interferon"@en . . . "Tamoxifen"@en . . . "Curcumin"@en . . . "Puromycin"@en . . . "Phorboxazoles"@en . . . "Bisantrene hydrochloride"@en . . . "Quinacrine"@en . . . "Octreotide acetate"@en . . . "Vinorelbine"@en . . . "Azacitidine"@en . . . "Lapatinib"@en . . . "Paclitaxel"@en . . . "Methotrexate"@en . . . "Cetuximab"@en . . . "Vindesine"@en . . . "Mitoxantrone hydrochloride"@en . . . "Vincristine"@en . . . "Bestatin"@en . . . "Methisazone"@en . . . "Camptothecin"@en . . . "Etoposide"@en . . . "Imatinib"@en . . . "Antimetabolites"@en . . . "Lonidamine"@en . . . "Trastuzumab"@en . . . "Rituximab"@en . . . "Folinic acid"@en . . . "Fludarabine"@en . . . "Bevacizumab"@en . . . "Cisplatin"@en . . . "Cancer--Chemotherapy"@en . . . "antineoplastic agents"@en . . . "Antitumorali"@it . . . "Cytostatikum" . . . "Anticancéreux"@fr . . . "Antineoplásicos"@es . . . "antineoplastic agents"@en . . . "Antineoplastic agents" . . . "制癌剤" . . . "Antineoplastic agents--Physiological effect" . . . "Antineoplastic agents--Side effects" . . . "Antineoplastic agents--Mechanism of action" . . . "Antineoplastic agents--Synthesis" . . . "Antineoplastic agents--Administration" . . . "Antineoplastic agents--Research" . . . "Antineoplastic agents--Metabolism" . . . "Antineoplastic agents--Analysis" . . . "Antineoplastic agents--Safety measures" . . . "Antineoplastic agents--Toxicology" . . . "Antineoplastic agents--Structure-activity relationships" . . . "Antineoplastic agents--Therapeutic use" . . . "Antineoplastic agents--Design" . . "Anticancer agents"@en . "Antineoplastic drugs"@en . "Antineoplastics"@en . "Antitumor agents"@en . "Antitumor drugs"@en . "Cytotoxic drugs"@en . "Inhibitors, Neoplasm"@en . "Neoplasm inhibitors"@en . _:b1191iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1191iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1191iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1191iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1191iddOtlocdOtgovauthoritiessubjectssh85005714 "1986-02-11T00:00:00"^^ . _:b1191iddOtlocdOtgovauthoritiessubjectssh85005714 "new"^^ . _:b1199iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1199iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1199iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1199iddOtlocdOtgovauthoritiessubjectssh85005714 . _:b1199iddOtlocdOtgovauthoritiessubjectssh85005714 "1993-05-03T10:53:17"^^ . _:b1199iddOtlocdOtgovauthoritiessubjectssh85005714 "revised"^^ .